Novocell Eliminates Paper Processes

“We have saved a tremendous amount of paper pushing by using ExpenseWatch.com. We no longer have an employee walking purchase orders around the office for signatures – now everyone can simply log in and approve!”

Lin Moody,
Director, Finance & Administration

 

About Novocell Inc.

 

 


Novocell Issues

  • Efficiency: Novocell needed to make its requisition process as efficient as possible. Time wasted pushing paper was a big problem.
  • Company Size: As a small research and development company, Novocell needed a cost-effective expense management system.
  • Manual Processes: Prior to ExpenseWatch.com, Novocell used a proprietary FileMaker database for its requisitions. Employees tracked down signature approvals manually.

Operating Expense Goals

  • Paperless Systems: Novocell needed to create an efficient process to track procurement procedures. Eliminating the paper trail and handling net purchasing more efficiently was paramount. The company wanted to simplify the entire process to flow as smoothly as possible.
  • Improved Requisition Process: Novocell wanted a system that would allow it to submit an electronic requisition and check the status online. Submitting and reviewing requisitions needed to consume less time and money.

ExpenseWatch.com Solution

  • Automation: Instead of filling out piles of paper forms, users submit electronic requisitions and check the status online. This provides far more information and reduces the time needed for reviews.
  • Dynamic Solution with Automatic Upgrades: The ExpenseWatch.com online infrastructure allows for new features and enhancements to be added without burdening Novocell with expensive upgrades.


About Novocell
Novocell is a private biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease.

Novocell is developing a technology platform that has the potential to treat a wide range of human degenerative diseases—these include liver disease, Parkinson’s disease, macular degeneration and stroke.

The Company’s initial focus is on pancreatic islet transportation for the treatment of diabetes.

< Complete case studies list | top ^

                         
Professional Services                        
Platform Features               Networked Vendor Partners        
Payable Invoices               Business Partners        
Purchasing               CRM Partners       Contact Us
Expense Reports       Pricing/Support Advantage       Travel Management       Careers
Spend Management       Scalable Expense Control       Accounting Partners       Executive Team
PRODUCTS & SERVICES   PROBLEMS WE SOLVE   WHY EXPENSEWATCH.COM   CUSTOMERS   PARTNERS   RESOURCE CENTER   ABOUT EXPENSEWATCH.COM
    Spending Challenges & Values by Company Role       Case Studies       News Releases    
    Automation       Webcasts       White Papers    
    Visibility       Select Customers       Articles    
    Control               Webcasts    
                    Awards